We are live on ! Find out more
AVAI

Atlas Venture Associates IX Portfolio holdings

AUM $11.8M
1-Year Est. Return 58.35%
This Fund
S&P 500
This Quarter Est. Return
-5.96%
1 Year Est. Return
-58.35%
3 Year Est. Return
-89.8%
5 Year Est. Return
-87.69%
10 Year Est. Return
–
AUM
$93.5M
AUM Growth
-$12.9M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 94.46%
2 Technology 3.24%
3 Communication Services 2.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTLA icon
1
Intellia Therapeutics
NTLA
$1.51B
$26.4M 28.28%
1,615,321
– –
SYBX
2
DELISTED
Synlogic
SYBX
$24.1M 25.81%
176,798
– –
SPRO icon
3
Spero Therapeutics
SPRO
$68.9M
$15.8M 16.95%
1,376,968
– –
SURF
4
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$13.1M 14.01%
4,645,453
– –
COGT icon
5
Cogent Biosciences
COGT
$6.76B
$8.81M 9.42%
840,384
– –
CBLK
6
DELISTED
Carbon Black, Inc. Common Stock
CBLK
$3.03M 3.24%
181,273
– –
SNAP icon
7
Snap
SNAP
$7.96B
$2.15M 2.3%
150,160
– –

Similar funds

EEPIS
Evolution Equity Partners II SARL Luxembourg $11.8M AUM 63.6% 1-Year Est. Return
LM
Lockheed Martin Bethesda, Maryland $12.1M AUM 46.13% 1-Year Est. Return
HMP9
Highland Management Partners 9 Cambridge, Massachusetts $12.6M AUM 85.13% 1-Year Est. Return
TCSAM
Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return
AEM
ACON Equity Management Washington, District of Columbia $13.8M AUM 62.17% 1-Year Est. Return
PT
Palantir Technologies Denver, Colorado $9.72M AUM 6.46% 1-Year Est. Return
AR
Acacia Research New York $14.1M AUM 50.98% 1-Year Est. Return
MM
Malka Meyer $8.77M AUM 64.77% 1-Year Est. Return

Atlas Venture Associates IX's Q2 2019 Portfolio in Review

As of Q2 2019, Atlas Venture Associates IX held 7 positions worth $93.5M, down 12% from $106M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2019: portfolio turnover was 0%. Atlas Venture Associates IX opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 96% a quarter earlier, followed by Technology and Communication Services.

  • Atlas Venture Associates IX's ten largest holdings make up 100% of its $93.5M portfolio in Q2 2019.
  • Atlas Venture Associates IX opened 0 new positions and closed 0 in Q2 2019.
  • Atlas Venture Associates IX's portfolio value fell 12% quarter-over-quarter to $93.5M.

Based on Atlas Venture Associates IX's 13F filing for Q2 2019, filed 6 Aug 2019.